Recent News

• 03.27.2026 - Cue Biopharma Announces CEO Transition
• 03.16.2026 - Cue Biopharma Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
• 02.12.2026 - Daniel Baker, M.D.
• 02.12.2026 - Lucinda Warren
• 02.12.2026 - Lucinda Warren

Recent Filings

• 03.27.2026 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 03.27.2026 - 8-K Current report
• 03.16.2026 - DEF 14A Other definitive proxy statements
• 03.16.2026 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.16.2026 - ARS Annual Report to Security Holders
• 03.16.2026 - EX-99.1 EX-99.1
• 03.16.2026 - S-3 Registration statement under Securities Act of 1933
• 03.16.2026 - 8-K Current report
• 03.06.2026 - PRE 14A Other preliminary proxy statements
• 02.18.2026 - 8-K Current report